Abstract
Classical complement pathway factor, C4 is required for experimental autoimmune myasthenia gravis (EAMG) pathogenesis. C4 is also a central component of the mannose binding lectin (MBL) pathway suggesting that this pathway might also be involved in MG pathogenesis. However, MBL gene deficient mice displayed intact anti-acetylcholine receptor (AChR)-immune response and neuromuscular junction (NMJ) IgG and complement accumulation following AChR-immunization. Moreover, no significant difference was observed between the serum MBL levels of 77 anti-AChR antibody positive generalized MG patients and 105 healthy controls. Therefore, MBL pathway does not play a role in EAMG/MG pathogenesis.
Original language | English (US) |
---|---|
Pages (from-to) | 40-45 |
Number of pages | 6 |
Journal | Journal of Neuroimmunology |
Volume | 208 |
Issue number | 1-2 |
DOIs | |
State | Published - Mar 31 2009 |
Externally published | Yes |
Keywords
- Autoimmunity
- Complement
- Lectin pathway
- Mannose binding lectin
- Myasthenia gravis
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
- Neurology
- Clinical Neurology